← Eichor
Study identifier: NCT06370312 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Analysis of Articular Biomarkers From Osteoarthritic Thumb Basal Joints

Condition: Osteoarthritis Thumb · Osteoarthritis, Knee · Metabolic Disease  ·  Sponsor: Region Skane

PhaseN/A
Planned participants120
Who can joinAll sexes, 25 Years to no upper limit
Healthy volunteersNo

About this study

The study project aims at examining molecular markers in synovial fluid, bone and articular cartilage from osteoarthritic thumb basal joints. The degradation of extracellular matrix (ECM) proteins in thumb basal joints will be evaluated in association to the metabolic profile of the patient, but we also aim to compare the ECM degradation and inflammatory profiles with articular cartilage degradation ECM profile from knee joints with osteoarthritis. A third aim is to evaluate associations between patient-reported hand function, pain, strength and range of thumb motion to analyses of synovial fluid.

This description comes directly from the study's public registry record.

Talk to the study team

Elisabeth Brogren, MD, PhD  ·  +46 40331723  ·  elisabeth.brogren@med.lu.se

My von Walter, MD

Always discuss trial participation with your own doctor first.

Locations (2)

Department of Hand Surgery, Skane University HospitalMalmö, Skåne County, SwedenNot Yet Recruiting
Aleris Specialistläkare HyllieMalmö, Skåne County, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06370312